Actively Recruiting
Phase I Study of JL19001 Injection Alone or with Standard Therapy for Adults with Advanced Solid Tumors or RelapsedRefractory B-Cell Non-Hodgkin Lymphoma
Led by Jecho Biopharmaceuticals Co., Ltd. · Updated on 2026-08-11
14
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a Phase I, multicenter, single-arm, open-label clinical trial to evaluate the safety and tolerability of JL19001 Injection, either alone or combined with standard therapy, in patients with advanced solid tumors AST or relapsedrefractory B-cell non-Hodgkin lymphoma rr B-NHL. This study aims to determine the maximum tolerated dose MTD and recommended maximum add-on dose RMAD for JL19001 through a traditional 3 3 dose escalation design across six planned dose levels ranging from 1 to 25 gkg administered by subcutaneous injection. Participants receive JL19001 Injection as monotherapy at escalating doses in Phase Ia, with doses of 1, 5, 10, 15, 20, and 25 gkg given subcutaneously. The study focuses on identifying the MTD and RMAD for JL19001. This open-label trial does not involve randomization or placebo controls. The trial may later include combination therapy phases, but only the Phase Ia monotherapy design is registered currently. During the trial, participants are monitored closely for dose-limiting toxicities within 28 days after the first dose and adverse events up to three years. Blood tests are conducted to measure JL19001 levels, immune cell counts, and various cytokines for up to one year. Researchers will also assess tumor response, disease control, progression-free and overall survival over a three-year period. The total participation duration may last up to three years with ongoing safety and efficacy assessments.
CONDITIONS
Brief Title
JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Research Team
H
Hongwei Ms Liu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here